Status: Not yet recruiting
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis
This study aims to evaluate the Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects with Healed Erosive Esophagitis
Participants needed: 384
Trial details
Phase: Phase 3Age: 19-75Biological sex: AllType: InterventionalSponsor: Onconic Therapeutics Inc.Updated: Jul 28, 2026
Eligibility criteria
Adult males or females aged ≥19 years and ≤75 years at the time of written infor... [+2]
Subjects diagnosed with upper gastrointestinal bleeding or perforation, gastric... [+2]